Abstract

Advances In Patient Tumoroid Screening

Michael Churchill, Lead Scientist, SEngine Precision Medicine

Ex-vivo organoid testing provides a 100-arm clinical trial for colorectal cancer patients.  The results of this trial have been used to improve patient outcomes beyond that offered by the current standard of care.